ASH 2021 Conference Coverage on VuMedi
ASH 2021 on a Study of Venetoclax and Low Dose Ara-C (VALDAC) to Target Rising Molecular MRD and Early Relapse in AML
By
ASH 2021 Conference Coverage on VuMedi
FEATURING
Tiong Ing Soo
By
ASH 2021 Conference Coverage on VuMedi
FEATURING
Tiong Ing Soo
Login to view comments.
Click here to Login
